• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Exonate to Begin Ph2b Trial of EXN407 for Diabetic Eye Disease

    BUSINESSWIRE

    Exonate: Dr. Rafiq Hasan Appointed As Non-Executive Director

    BUSINESSWIRE

    Exonate launches diabetic macular oedema trial

    PHARMATIMES

    Exonate announces the initiation of Phase Ib/II clinical trial

    GLOBENEWSWIRE

    Exonate in collaboration with Janssen patient in ph Ib/II trial for EXN 407

    PHARMABIZ

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.